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Staphylococci are important causes of nosocomial and medical-device-related infections. Their virulence is
attributed to the elaboration of biofilms that protect the organisms from immune system clearance and to
increased resistance to phagocytosis and antibiotics. Photodynamic treatment (PDT) has been proposed as an
alternative approach for the inactivation of bacteria in biofilms. In this study, we have investigated the effect
of the photodynamic action of toluidine blue O (TBO) on the viability and structure of biofilms of Staphylo-
coccus epidermidis and of a methicillin-resistant Staphylococcus aureus strain. Significant inactivation of cells
was observed when staphylococcal biofilms were exposed to TBO and laser simultaneously. The effect was
found to be light dose dependent. Confocal laser scanning microscopic study suggested damage to bacterial cell
membranes in photodynamically treated biofilms. In addition, scanning electron microscopy provided direct
evidence for the disruption of biofilm structure and a decrease in cell numbers in photodynamically treated
biofilms. Furthermore, the treatment of biofilms with tetrasodium EDTA followed by PDT enhanced the
photodynamic efficacy of TBO in S. epidermidis, but not in S. aureus, biofilms. The results suggest that
photodynamic treatment may be a useful approach for the inactivation of staphylococcal biofilms adhering to
solid surfaces of medical implants.
Staphylococcus aureus and Staphylococcus epidermidis are
the most common causes of osteomyelitis, endocarditis, and
catheter- and orthopedic-implant-associated infections in hos-
pitalized patients (7, 8, 13, 19, 32). These bacteria grow as
biofilms, which are sessile microbial communities embedded in
a self-produced extracellular polymer matrix composed mainly
of a large polysaccharide referred to as polysaccharide inter-
cellular adhesion (PIA) (5). The management of medical-de-
vice-associated infections is becoming increasingly difficult due
to their inherent resistance to antibiotic treatments (11, 18).
Although it is not yet clear how biofilms resist antibiotics,
several mechanisms have been suggested, such as decreased
penetration of the antibiotics, slow growth of cells within the
biofilms, the activation of stress responses, and the emergence
of biofilm-specific phenotypes (7, 11, 18). To overcome anti-
microbial resistance, several new approaches, such as the use
of analogues of quorum-sensing signal molecules (7) and en-
zymatic disruption of biofilms (29), are being investigated.
However, more-comprehensive research is required for the
effective application of these techniques.
Photodynamic treatment (PDT) is a process in which micro-
organisms are treated with a photosensitizing drug and then
irradiated with low-intensity visible light of the appropriate
wavelength (16). The resulting photochemical reactions gen-
erate cytotoxic reactive oxygen species, such as singlet oxygen
and free radicals, which are able to exert bactericidal effect.
Several studies have reported on the photodynamic inactiva-
tion of gram-positive and gram-negative bacteria in planktonic
cultures using different photosensitizing drugs (16, 22, 23, 25).
Although PDT is being actively investigated for the eradication
of bacterial biofilms growing in dental plaques and on oral
implants (26, 27, 28), there are very few studies on the effect of
PDT on staphylococcal biofilms. These studies have shown that
the photodynamic efficacies of the photosensitizers for the
inactivation of biofilms differ from those of planktonic cultures.
Specifically, Lin et al. (17) demonstrated that the light doses
required to inactivate S. aureus biofilms using merocyanine 540
are much higher than those used to inactivate planktonic cul-
tures, due to hindrance of the penetration of light within the
biofilms. Using confocal laser scanning microscopy (CLSM),
Zanin et al. (30) demonstrated that photosensitization in Strep-
tococcus mutans biofilms occurs only in the outer layers due to
the inability of the photosensitizer to diffuse into inner regions.
Likewise, it has been reported that the presence of PIA/extra-
cellular polymeric substance (EPS) in the biofilm affects the
penetration of the photosensitizer and thereby decreases the
effect of the photosensitization process (14, 31). Therefore,
approaches that increase the permeability of the drugs in the
biofilms may be beneficial for enhancement of the photody-
namic efficacy of the drugs.
Recent studies have shown that metal chelators, such as
disodium and tetrasodium EDTA (TEDTA) cause loss of vi-
ability and enhance the sensitivity of both gram-positive and
gram-negative bacteria embedded in biofilms to antimicrobial
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agents, possibly by disrupting biofilm structure (1, 20). EDTA
has also been used for increasing the permeability of some
anionic photosensitizing drugs in gram-negative microorgan-
isms (3). Thus, we hypothesized that the treatment of biofilms
with metal chelators could enhance the photosensitizer pene-
tration inside biofilms and thereby increase the efficacy of the
photodynamic treatment.
Toluidine blue O (TBO) is a cationic phenothiazine dye that
has been well studied as an antibacterial photosensitizer (10,
24, 25, 30, 31). To the best of our knowledge, the photosensi-
tizing effect of this drug on the viability and structure of staph-
ylococcal biofilms has not been investigated. Thus, in the
present study, we examined the photodynamic effects of TBO
on the viability and architecture of staphylococcal biofilms.
Further, we investigated the effect of the pretreatment of bio-
films with TEDTA on the efficacy of the photodynamic inac-
tivation of staphylococci.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The microorganisms used in this
study were S. epidermidis 1457 and methicillin-resistant S. aureus LP. S. epider-
midis 1457, a standard biofilm-producing strain, was a gift from Tim Foster
(Department of Microbiology, Dublin, Ireland). S. aureus LP was a clinical
isolate provided by the Department of Microbiology, University of Pavia, Pavia,
Italy. Bacteria were routinely grown overnight in tryptic soy broth (TSB) (Difco,
Detroit, MI) under aerobic conditions at 37°C using a shaker incubator (New
Brunswick Scientific Co., Edison, NJ).
Biofilm growth. For screening biofilm formation by the staphylococci, bacteria
were grown on Congo red agar as described by Freeman et al. (12). Briefly, brain
heart infusion broth (Difco) (37 g/liter), sucrose (50 g/liter), and agar (10 g/liter)
were autoclaved, and a separately autoclaved Congo red solution (Sigma, St.
Louis, MO) was added at 55°C to give a final concentration of 0.8 g/liter. Colony
morphology was examined after 24 h at 37°C. For biofilm assays, overnight
cultures of S. epidermidis and S. aureus were diluted at 1:200 and 1:50, respec-
tively, in TSB containing 0.25% glucose. Aliquots (200 l) of the diluted bacterial
suspensions were inoculated into 96-well flat-bottomed sterile polystyrene mi-
croplates (Costar; Corning, Inc., NY) and incubated for 16 h at 37°C. For
enhancing S. aureus biofilm formation in all the assays, microplates were coated
with 20% (vol/vol) human plasma in carbonate buffer (50 mM sodium carbonate,
pH 9.5) (2). Biofilm formation by bacteria was detected by the method described
by Christensen et al. (6). Briefly, biofilms formed on the plates were washed twice
with phosphate-buffered saline (PBS) (137 mM NaCl, 2.7 mM KCl, 4.3 mM
Na2HPO4, pH 7.4) to remove the planktonic cells. Then, the cells were fixed with
95% ethanol for 10 min and stained with 0.1% crystal violet for 15 min, and after
several washings, the wells were air dried. For a quantitative estimation of
biofilms, crystal violet was solubilized with 10% glacial acetic acid and absor-
bance of the solubilized dye was determined at 590 nm in a microplate reader
(model 680; Bio-Rad Laboratories, Inc., Hercules, CA).
Photosensitizer. A stock solution of 1 mM TBO (Sigma) was prepared in
distilled water, filter sterilized, and stored at 4°C in the dark. When used, the
stock solution was appropriately diluted in PBS to obtain the desired concen-
tration.
Photodynamic inactivation studies. To investigate the effect of PDT, 100 l of
diluted TBO (10 to 80 M) was added to each well and the plates were incubated
in the dark for 30 min at 37°C. Wells used as controls were incubated with PBS
only. TBO-treated biofilms were irradiated with a 640-nm wavelength of light
using a model HL6364DG diode laser (Optnext Lasers Japan, Inc., Nagano-Ken,
Japan) at different light doses. Laser light was focused to a spot with a 1-cm
diameter using an appropriate lens. The intensity of the light source at the
position of the bacterial cells was 42 mW/cm2. The power output was measured
by using a power meter (Thorlabs GmbH, Munich, Germany). Following irra-
diation, TBO was carefully removed from the microwells and the biofilms were
washed once with fresh PBS. The biofilms were scraped carefully, sonicated, and
then vortexed for 20 s to homogenize the samples. Treated and untreated
samples were serially diluted, plated on the TSB agar plates, and incubated for
24 h at 37°C in the dark. For each set of measurements, controls consisting of
biofilms treated with TBO but not exposed to light (SL), exposed to light only
(SL), and treated with neither TBO nor light (SL) were included. S and L
stand for “sensitizer” and “light” respectively. Cell survival was expressed as the
ratio of the numbers of CFU of bacteria treated with TBO and light to the
numbers of CFU treated with TBO alone.
Effect of TEDTA. To assess the effect of TEDTA on the viability of cells in
biofilms, growth medium was aspirated from biofilm-containing wells; 100-l
amounts of PBS, including different concentrations of TEDTA, were added; and
the microplates were incubated at 37°C for increasing periods of time. Subse-
quently, the wells were washed once with PBS and adherent bacteria were
scraped from the wells and serially diluted and plated.
The effect of TEDTA on the photodynamic action of TBO was analyzed by
treating biofilms with 20 mM TEDTA for 1 h prior to exposure to TBO and light.
Controls consisted of biofilms treated with TEDTA and TBO but not exposed to
light (TEDTASL), biofilms treated with TEDTA only (TEDTASL), or
biofilms treated with neither TBO/light nor TEDTA (TEDTASL). For both
treated and untreated biofilms, colony assays were performed as described pre-
viously.
CLSM studies. For confocal studies, 500 l of diluted cell suspensions were
dispensed into 24-well microplates (Costar) containing glass coverslips. To ex-
amine biofilm formation by S. aureus, the coverslips were coated with human
plasma, as mentioned previously. Coverslips containing cell suspensions were
incubated for 16 h at 37°C. To determine the viability of bacteria within the
biofilms after photodynamic treatment, a BacLight Live/Dead viability kit (Mo-
lecular Probes, Eugene, OR) was used. The kit includes two fluorescent nucleic
acid stains: SYTO9 and propidium iodide. SYTO9 penetrates both viable and
nonviable bacteria, while propidium iodide penetrates bacteria with damaged
membranes and quenches SYTO9 fluorescence. Dead cells, which take up pro-
pidium iodide, fluoresce red, and cells fluorescing green are deemed viable. For
assessing viability, 1 l of the stock solution of each stain was added to 3 ml of
PBS and, after being mixed, 500 l of the solution was dispensed into 24-well
microplates containing treated and untreated biofilms and incubated at 22°C for
15 min in the dark. Stained biofilms were examined under a Leica CLSM (model
TCS SPII; Leica, Heidelberg, Germany) using a 40 oil immersion objective.
The excitation and emission wavelengths used for detecting SYTO9 were 488
and 525 nm, respectively. Propidium iodide was excited at 520 nm, and its
emission was monitored at 620 nm. The optical sections of 0.9 m were collected
over the complete thickness of the biofilm, and for each sample, images from
three randomly selected positions were acquired. The resulting stacks of images
were analyzed using Leica confocal software and subsequently processed using
ImageJ software (Wayne Rasband, National Institutes of Health).
SEM. S. epidermidis was grown in TSB on sterile Thermanox plastic coverslips
(polyolefin) (Nalge Nunc International, Rochester, NY). S. aureus cells were
grown as described above except that the coverslips were precoated with 20%
human plasma. Following photodynamic treatment, samples were washed sev-
eral times and then fixed for scanning electron microscopy (SEM) with 2.5%
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.2, for 1 h at 4°C. After additional
washing, the samples were incubated using increasing concentrations of ethanol
(25, 50, 75, and 96%) for 10 min, dried to the critical point using an Emitech
K-850 apparatus, and placed on a mounting base. Finally, the specimens were
coated with gold and examined under an SEM (model EVO 50 EP; Zeiss-Leica,
Cambridge, United Kingdom) (9).
Statistical methods. An unpaired, two-sided Student t test was used for eval-
uating the differences between the means of the results for the control and
treated samples. P values of less than 0.05 were considered significant.
RESULTS
Biofilm formation. As indicated by the results of the crystal
violet assay, both the S. epidermidis 1457 and S. aureus LP
strains produced biofilms (Fig. 1). However, biofilm formation
was substantially higher for S. epidermidis 1457 than for the
clinical isolate S. aureus LP. In confirmation of this, the colony
morphology of S. epidermidis 1457 on Congo red agar was a
black coloration with a dry crystalline consistency, while for S.
aureus, the colonies were pink (data not shown).
Photodynamic inactivation. Our preliminary experiments
showed that the treatment of biofilms with 40 M TBO in the
dark did not exhibit any toxicity against the bacterial cells.
Similarly, the exposure of cells to 640 nm of light alone did not
cause any change in cell survival compared to the survival rates
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of untreated controls. In Fig. 2, the surviving fraction as a
function of light dose of cells in biofilms treated with 40 M
TBO is presented. The survival of both S. aureus and S. epi-
dermidis in biofilms decreased gradually with increasing light
doses; however, at a given light dose, a more remarkable de-
crease was observed for S. epidermidis. At a lower light dose
(25 J/cm2), the cell survival of S. epidermidis was almost 10-fold
lower than that of S. aureus. This difference was highly signif-
icant (P  0.05). Of note, the use of TBO concentrations
higher than 40 M did not lead to a remarkable change in
phototoxicity (data not shown).
Effect of TEDTA treatment on biofilm stability. TEDTA at
high concentrations (40 mg/ml, 89 mM) has been shown to
affect the structure and viability of many biofilm-forming bac-
teria, including staphylococci, when incubated with them for
long periods of time (20 h) (20). In order to determine the
potential role of TEDTA as an enhancer of the photodynamic
action of TBO, the effects of different concentrations and in-
cubation times on staphylococcal survival with TEDTA were
determined. As shown in Fig. 3A, cell survival was inversely
related to the addition of increasing amounts of TEDTA to the
wells. More specifically, the numbers of bacteria treated with
20 mM TEDTA for 1 h were reduced by almost 0.8 log and 1.0
log for S. epidermidis and S. aureus, respectively, compared to
the survival rates of untreated controls. Incubation time also
affected the survival of cells treated with 20 mM TEDTA (data
not shown).
In Fig. 3B, we show the effect of pretreatment of biofilms
with TEDTA on the photodynamic action of TBO at a light
dose of 100 J/cm2. Under these conditions, the survival of S.
epidermidis cells was reduced by almost 1.0 log with respect to
the survival of cells treated with the combination of TBO and
light alone (P  0.05). Surprisingly, TEDTA pretreatment did
not induce a significant cell death enhancement in the photo-
dynamically treated S. aureus biofilm compared to cell death in
biofilm not treated with TEDTA (P  0.05).
CLSM of photodynamically treated biofilms. To better un-
derstand the effect of PDT on the viability of bacteria with or
FIG. 1. Biofilm assay for staphylococcal strains. Biofilms were
grown in 96-well microtiter plates for 16 h at 37°C, and adherent cells
were stained with crystal violet as described in Materials and Methods.
The values represented are the means  standard errors of the means
of the results of two experiments done in duplicate plates. In each
plate, four wells were used for the assay.
FIG. 2. Light dose-dependent killing of staphylococcal cells treated
with TBO. Biofilms were incubated with TBO (40 M) for 30 min in
the dark and subsequently irradiated with different light doses. f, S.
epidermidis 1457; F, S. aureus LP. Surviving fractions of cells are
expressed as the ratios of numbers of CFU from bacteria treated with
TBO and light over numbers of CFU of bacteria treated with TBO
alone. The values represented are the means of the results for dupli-
cate biofilms and three separate experiments. Error bars indicate stan-
dard errors of the means.
FIG. 3. Effect of pretreatment with TEDTA on photodynamic ac-
tion of TBO on biofilms. Biofilms grown for 16 h were treated with
TEDTA for 1 h. (A) Effects of different concentrations of TEDTA on
the viability of cells in biofilms. White bar, S. epidermidis 1457; gray
bar, S. aureus LP. (B) Comparison of surviving fractions of PDT-
subjected biofilms with and without TEDTA pretreatment. Biofilms
pretreated with TEDTA (20 mM, 1 h) were incubated with TBO (40
M) for 30 min and then irradiated with light (100 J/cm2). Dark-gray
bar, not treated with TBO or exposed to light (SL); light-gray bar,
treated with TBO in the absence of light (SL); white bar, treated
with TBO and light (SL); dark-gray hatched bar, treated with
TEDTA in the absence of TBO and light (TEDTASL); light-gray
hatched bar, treated with TEDTA and TBO in the absence of light
(TEDTASL); white hatched bar, pretreated with TEDTA and
exposed to TBO and light (TEDTASL). *, P  0.05, showing the
statistical difference between PDT-subjected biofilms with or without
TEDTA. The surviving fraction of pretreated biofilm is expressed as
the ratio of numbers of CFU of bacteria treated with TEDTASL
over numbers of CFU of bacteria treated with TEDTASL. The
surviving fraction of untreated biofilms subjected to PDT is expressed
as the ratio of numbers of CFU of bacteria treated with TBO and light
(SL) over numbers of CFU of bacteria treated with neither TBO
nor light (SL). The values represented are the means of the results
for duplicate biofilms in three separate experiments. Error bars indi-
cate standard errors of the means.
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without pretreatment with TEDTA, a CLSM study was car-
ried out.
In biofilms incubated with TBO in the absence of light (Fig.
4A, panels a and d), CLSM images of S. epidermidis and S.
aureus showed multilayered clumps of bacteria and the major-
ity of the cells showed green fluorescence. The images for both
the species were similar to those acquired in the absence of
TBO (data not shown). Biofilms treated with TBO and then
irradiated at 100 J/cm2 showed cells fluorescing both green
(live) and red (dead) (Fig. 4A, panels b and e). Upon irradi-
ation at 200 J/cm2, predominantly red-fluorescing cells were
observed (Fig. 4A, panels c and f). In addition, these biofilms
were less dense than the controls.
Figure 4B shows the combined effects of TEDTA pretreat-
ment and the photodynamic action of TBO on the viability of
S. epidermidis 1457 and S. aureus LP biofilms. Most of the cells
showed green fluorescence, and very few cells were stained
with propidium iodide in biofilms treated with TEDTA alone
(Fig. 4B, panels a and c). This staining profile was similar to
those observed with staphylococcal biofilms treated (Fig. 4A,
panels a and d) or untreated (data not shown) with TBO in the
dark. In contrast, following exposure to TEDTA, biofilms in-
FIG. 4. CLSM images of PDT-treated staphylococcal biofilms. Biofilms were grown for 16 h and then treated with TEDTA (20 mM, 1 h) before
the photodynamic treatment with TBO (40 m, 30 min) and light. Biofilms were stained with BacLight Live/Dead stain. (A) Effect of light dose
on the viability of bacteria. SL, 0 J/cm2 (a, d); SL, 100 J/cm2 (b, e); SL, 200 J/cm2 (c, f). (B) Effect of TEDTA treatment on PDT.
TEDTASL (a, c); TEDTASL, 100 J/cm2 (b, d). Sagittal sections of the biofilms are shown below and to the right of each panel. Scale bar:
75 m.
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cubated with TBO and irradiated at 100 J/cm2 showed more
red-fluorescing cells than those biofilms exposed to PDT with-
out TEDTA pretreatment (Fig. 4B, panels b and d).
Morphological alterations. To visualize the effect of PDT on
the morphology of the biofilms, SEM studies were carried out.
Large cellular aggregates surrounded by extracellular matrix
could be observed in the biofilms produced by both S. epider-
midis 1457 and S. aureus LP treated with TBO in the dark (Fig.
5, panels a and b). These images were very similar to those of
untreated controls (data not shown).
Irradiation in the presence of 40 M TBO led to a light
dose-dependent disruption of the biofilms. In fact, as the light
dose increased, the number of adherent bacteria was reduced
and very few aggregated colonies were observed in both the
staphylococcal biofilms. Most of the bacteria were single cells
or organized in short chains (Fig. 5, panels e and f). The
treatment of biofilms with TEDTA also resulted in the disso-
ciation of large colonies of bacteria (Fig. 5, panels g and h). A
more remarkable reduction in the cell numbers of both S.
epidermidis and S. aureus was observed when biofilms were
treated with TEDTA and then subjected to photodynamic
treatment (100 J/cm2) (Fig. 5, panels i and j) compared to cell
numbers in biofilms treated in the absence of the chelator (Fig.
5, panels c and d). Nevertheless, in contrast to the membrane
damage observed by CLSM, no apparent alteration in the
morphology of cell surfaces could be noted in PDT-subjected
or TEDTA-treated biofilms of S. epidermidis and S. aureus.
DISCUSSION
A number of studies have shown that TBO is phototoxic to
several planktonic gram-positive and gram-negative bacteria
(10, 22, 24). The photodynamic efficacy of TBO has also been
demonstrated in several oral biofilm models (30, 31). In this
study we investigated the effect of the photodynamic action of
TBO on the viability and structure of staphylococcal biofilms,
which are common causative agents of medical-device-related
infections.
In our study, different surfaces, such as glass and plastic,
were used to produce biofilm formation by S. epidermidis and
S. aureus. It is not clear whether the biochemical natures and
architectures of the biofilms formed on these surfaces are
different, as both the physicochemical properties of surfaces
and the bacterial surface may influence attachment and colo-
nization (15). In this context, we and others (2) found that S.
aureus produced better biofilms on surfaces coated with human
plasma. This probably reflects the crucial requirement of
plasma proteins for the early attachment by S. aureus to the
surfaces.
The results of this study show that a large number of S.
aureus and S. epidermidis cells could be inactivated when bio-
films were irradiated by using a diode laser in the presence of
TBO. The threshold concentration of the TBO required for
achieving a significant light dose response was 40 M for both
S. aureus and S. epidermidis biofilms. As reported by others (10,
24), the TBO concentration and the light dose (25 to 200
J/cm2) used for the photoinactivation of biofilms were consid-
erably higher than those required to inactivate S. aureus sus-
pensions. The differences in the photodynamic efficacies of the
drug could be due to several reasons. In fact, cells growing in
a biofilm differ from their planktonic counterparts in a number
of respects, such as the cell wall composition, rate of growth,
and presence of PIA, which may hinder the uptake of the
photosensitizer and penetration of light and thereby reduce
the photosensitizing process (7, 31). Our results also show that
the photosensitivity of S. epidermidis 1457 biofilm was higher
than that of S. aureus LP biofilm when they were irradiated
under similar conditions, and this difference was more signif-
icant at lower light doses. In confirmation of this, Gad et al.
(14) have reported a higher photokilling of S. epidermidis than
of S. aureus using methylene blue, which is a photosensitizer
similar to TBO. Abundant production of PIA has been sug-
gested to obstruct the diffusion of the photosensitizer through
the matrix, thus reducing the susceptibility of biofilms to pho-
tosensitization. In contrast with this observation, we found
that, despite the reduced biofilm produced by S. aureus, these
microbial cells appeared more resistant to photokilling, sug-
gesting that other factors, such as intrinsic variation in the cell
wall thickness, influence the dye uptake (4).
Of note, the results of our study show that the photodynamic
efficacy of TBO for the inactivation of staphylococcal biofilms
is higher than that reported for oral biofilms (30, 31). These
variations could be due to different experimental conditions
and/or the diverse nature of the biofilms produced by staphy-
lococci and streptococci.
CLSM images of biofilms subjected to photosensitization
showed an increased permeability of bacterial cells to pro-
pidium iodide, indicating that the cell membrane could be an
important site of damage in TBO-mediated photodamage.
This observation is consistent with the results of previous stud-
ies on the photodynamic effects of TBO in planktonic cultures
of bacteria and yeast (16, 24) and with the high affinity of TBO
for polyphosphates, lipids, and membrane proteins (24).
Furthermore, the presence of dead cells throughout the
thickness of the biofilm implies that there is no hindrance to
photosensitizer diffusion and light penetration. In addition, the
reduced cell density observed following photodynamic treat-
ment indicates the loss of cells within the biofilms. Although
the reason for these changes is not obvious, damage to bacte-
rial membranes due to PDT may reduce cell-to-cell contact or
cell-to-EPS binding, causing a loss of cells within the biofilms.
These observations are consistent with the results reported by
Wood et al. (27) which show the loss of biofilm mass in oral
plaque following PDT using pyridinum zinc(II) phthalocya-
nine. Our results from CLSM studies were also consistent with
the alteration in biofilm morphology observed by using SEM.
In the present communication, we also found that the incu-
bation of staphyloccocal biofilms with high concentrations of
TEDTA for a short period of time resulted in a disruption
of the large clusters of cells without compromising the viability
of cells. This effect is probably due to the sequestration of
divalent cations, such as Ca2 and Mg2, that are important
for maintaining the integrity of EPS in the biofilm (1, 20). A
different effect of TEDTA pretreatment was observed when S.
epidermidis or S. aureus cells were subjected to PDT. When S.
epidermidis cells were exposed to the chelator, a strong disrup-
tion of biofilm structure was noticed. This enhancement could
be due to the destabilization of the biofilm structure, which
makes cells more accessible to drug and light penetration.
However, although there was disruption of the S. aureus bio-
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FIG. 5. SEM images of PDT-subjected staphylococcal biofilms. Biofilms were grown as reported in Materials and Methods. Biofilms treated
with 40 M TBO for 30 min in the dark (a, b); irradiated with a light dose of 100 J/cm2 (c, d); or irradiated with a light dose of 200 J/cm2 (e, f).
Biofilms pretreated with 20 mM TEDTA for 1 h without PDT (g, h) or subjected to PDT of 100 J/cm2 (i, j). Magnification, 1,000.
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film exposed to the chelator, no significant enhancement in
PDT results was observed. The reason for this lack of effect by
PDT is unclear.
Studies by Banin et al. (1) have shown that combined treat-
ment of chelating agents such as EDTA with the antibiotic
gentamicin could enhance the killing of Pseudomonas aerugi-
nosa embedded in the biofilms by dispersing the biofilm struc-
ture and increasing the permeability to antibiotics. The com-
bined action of minocycline and EDTA has also been used to
increase the killing of antibiotic-resistant S. aureus cells (21).
Consistent with these observations, we found that the subjec-
tion of biofilms to TEDTA and PDT could enhance killing in
S. epidermidis biofilms.
To the best of our knowledge, there are no published reports
on the combined use of chelating agents and PDT for the
inactivation of biofilms. PDT is proposed as an alternative
antimicrobial method for the inactivation of biofilm-related
diseases owing to several advantages over the conventional
antibacterial treatment. However, the efficacy of PDT for bio-
film treatment depends mainly on the penetration of the pho-
tosensitizer and light to the deeper layers. Our studies show
that pretreatment of biofilms with chelating agents, such as
TEDTA, can enhance the efficacy of PDT by dispersing the
biofilm structure and thereby enhancing the photosensitizer
and light penetration. Thus, the use of combined TEDTA and
PDT has the intrinsic advantage of treating and eradicating
even thick biofilms and circumventing the disadvantage of us-
ing antibiotics, with the consequent generation of antimicro-
bial resistance.
In summary, TBO may be a potential photosensitizer for the
inactivation of staphylococcal biofilms for many device-related
infections which are accessible to light. Hence, an experimental
approach involving a combination of TEDTA and PDT in
treating biofilm-associated medical devices may be worth ex-
ploring.
ACKNOWLEDGMENTS
This work was partially funded by a grant from the Italian Ministero
della Salute (identification code RF-IOR-2006-349032; Opportunistic
bacteria in orthopaedic implant infections: new strategies of molecular
and gene therapies). M. Sharma is a recipient of a scholarship for
Indian researchers under the project BOIND22703, MIUR, Italy.
We are grateful to Patrizia Vaghi and Dario Picenoni for their
technical assistance in the confocal and scanning electron microscopic
studies.
REFERENCES
1. Banin, E., K. M. Brady, and E. P. Greenberg. 2006. Chelator-induced dis-
persal and killing of Pseudomonas aeruginosa cells in a biofilm. Appl. Envi-
ron. Microbiol. 72:2064–2069.
2. Beenken, K. E., J. S. Blevins, and M. S. Smeltzer. 2003. Mutation of sarA in
Staphylococcus aureus limits biofilm formation. Infect. Immun. 71:4206–
4211.
3. Bertoloni, G., F. Rossi, G. Valduga, G. Jori, and J. van Lier. 1990. Photo-
sensitizing activity of water- and lipid-soluble phthalocyanines on Escherichia
coli. FEMS Microbiol. Lett. 59:149–155.
4. Boyle-Vavra, S., H. Labischinski, C. C. Ebert, K. Ehlert, and R. S. Daum.
2001. A spectrum of changes occurs in peptidoglycan composition of glyco-
peptide-intermediate clinical Staphylococcus aureus isolates. Antimicrob.
Agents Chemother. 45:280–287.
5. Chokr, A., D. Watier, H. Eleaume, B. Pangon, J. C. Ghnassia, D. Mack, and
S. Jabbouri. 2006. Correlation between biofilm formation and production of
polysaccharide intercellular adhesin in clinical isolates of coagulase-negative
staphylococci. Int. J. Med. Microbiol. 296:381–388.
6. Christensen, G. D., W. A. Simpson, J. J. Younger, L. M. Baddour, F. F.
Barrett, D. M. Melton, and E. H. Beachey. 1985. Adherence of coagulase-
negative staphylococci to plastic tissue culture plates: a quantitative model
for the adherence of staphylococci to medical devices. J. Clin. Microbiol.
22:996–1006.
7. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms:
a common cause of persistent infections. Science 284:1318–1322.
8. Costerton, W., R. Veeh, M. Shirtliff, M. Pasmore, C. Post, and G. Ehrlich.
2003. The application of biofilm science to the study and control of chronic
bacterial infections. J. Clin. Investig. 112:1466–1477.
9. Del Curto, B., M. F. Brunella, C. Giordano, M. P. Pedeferri, V. Valtulina, L.
Visai, and A. Cigada. 2005. Decreased bacterial adhesion to surface treated
titanium. Int. J. Artif. Organs 28:718–730.
10. Demidova, T. N., and M. R. Hamblin. 2005. Effect of cell-photosensitizer
binding and cell density on microbial photoinactivation. Antimicrob. Agents
Chemother. 49:2329–2335.
11. Donlan, R. M., and J. W. Costerton. 2002. Biofilms: survival mechanisms of
clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167–193.
12. Freeman, D. J., F. R. Falkiner, and C. T. Keane. 1989. New method for
detecting slime production by coagulase negative staphylococci. J. Clin.
Pathol. 42:872–874.
13. Fux, C. A., P. Stoodley, L. Hall-Stoodley, and J. W. Costerton. 2003. Bacte-
rial biofilms: a diagnostic and therapeutic challenge. Expert Rev. Anti-Infect.
Ther. 1:667–683.
14. Gad, F., T. Zahra, T. Hasan, and M. R. Hamblin. 2004. Effects of growth
phase and extracellular slime on photodynamic inactivation of gram-positive
pathogenic bacteria. Antimicrob. Agents Chemother. 48:2173–2178.
15. Heilmann, C., M. Hussain, G. Peters, and F. Go¨tz. 1997. Evidence for
autolysin-mediated primary attachment of Staphylococcus epidermidis to a
polystyrene surface. Mol. Microbiol. 24:1013–1024.
16. Jori, G. 2006. Photodynamic therapy of microbial infections: state of the art
and perspectives. J. Environ. Pathol. Toxicol. Oncol. 25:505–519.
17. Lin, H. Y., C. T. Chen, and C. T. Huang. 2004. Use of merocyanine 540 for
photodynamic inactivation of Staphylococcus aureus planktonic and biofilm
cells. Appl. Environ. Microbiol. 70:6453–6458.
18. Mah, T. F., and G. A. O’Toole. 2001. Mechanisms of biofilm resistance to
antimicrobial agents. Trends Microbiol. 9:34–39.
19. Moreillon, P., and Y. A. Que. 2004. Infective endocarditis. Lancet 363:139–
149.
20. Percival, S. L., P. Kite, K. Eastwood, R. Murga, J. Carr, M. J. Arduino, and
R. M. Donlan. 2005. Tetrasodium EDTA as a novel central venous catheter
lock solution against biofilm. Infect. Control Hosp. Epidemiol. 26:515–519.
21. Raad, I., H. Hanna, T. Dvorak, G. Chaiban, and R. Hachem. 2007. Optimal
antimicrobial catheter lock solution using different combinations of minocy-
cline, EDTA, and 25 percent ethanol rapidly eradicates organisms embed-
ded in biofilm. Antimicrob. Agents Chemother. 51:78–83.
22. Tang, H. M., M. R. Hamblin, and C. M. Yow. 2007. A comparative in vitro
photoinactivation study of clinical isolates of multidrug-resistant pathogens.
J. Infect. Chemother. 13:87–91.
23. Tegos, G. P., M. Anbe, C. Yang, T. N. Demidova, M. Satti, P. Mroz, S.
Janjua, F. Gad, and M. R. Hamblin. 2006. Protease-stable polycationic
photosensitizer conjugates between polyethyleneneimine and chlorin (e6)
for broad-spectrum antimicrobial photoinactivation. Antimicrob. Agents
Chemother. 50:1402–1410.
24. Usacheva, M. N., M. C. Teichert, and M. A. Biel. 2001. Comparison of the
methylene blue and toluidine blue photobactericidal efficacy against gram-
positive and gram-negative microorganisms. Lasers Surg. Med. 29:165–173.
25. Wainwright, M. 1998. Photodynamic antimicrobial chemotherapy (PACT).
J. Antimicrob. Chemother. 42:13–28.
26. Wilson, M. 2004. Lethal photosensitisation of oral bacteria and its potential
application in the photodynamic therapy of oral infections. Photochem.
Photobiol. Sci. 3:412–418.
27. Wood, S., B. Nattress, J. Kirkham, R. Shore, S. Brookes, J. Griffiths, and C.
Robinson. 1999. An in vitro study of the use of photodynamic therapy for the
treatment of natural oral plaque biofilms formed in vivo. J. Photochem.
Photobiol. B 50:1–7.
28. Wood, S., D. Metcalf, D. Devine, and C. Robinson. 2006. Erythrosine is a
potential photosensitizer for the photodynamic therapy of oral plaque bio-
films. J. Antimicrob. Chemother. 57:680–684.
29. Wu, J. A., C. Kusuma, J. J. Mond, and J. F. Kokai-Kun. 2003. Lysostaphin
disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on
artificial surfaces. Antimicrob. Agents Chemother. 47:3407–3414.
30. Zanin, I. C., R. B. Gonc¸alves, A. B. Junior, C. K. Hope, and J. Pratten. 2005.
Susceptibility of Streptococcus mutans biofilms to photodynamic therapy: an
in vitro study. J. Antimicrob. Chemother. 56:324–330.
31. Zanin, I. C., M. M. Lobo, L. K. Rodrigues, L. A. Pimenta, J. F. Ho¨fling, and
R. B. Gonc¸alves. 2006. Photosensitization of in vitro biofilms by toluidine
blue O combined with light-emitting diode. Eur. J. Oral Sci. 114:64–69.
32. Zimmerli, W., A. Trampuz, and P. E. Ochsner. 2004. Prosthetic-joint infec-
tions. N. Engl. J. Med. 351:1645–1654.
VOL. 52, 2008 PHOTODYNAMIC TREATMENT OF STAPHYLOCOCCAL BIOFILMS 305
